Pediatric delirium: evaluating the gold standard

Gabrielle Silver1, Julia Kearney2, Chani Traube1

  • 1Weill Cornell Medical College,New York,New York.

Insights

Child psychiatrists demonstrated high reliability diagnosing pediatric delirium using psychiatric exams. This diagnostic method is effective even in critically ill, young, and developmentally delayed children.

Area of Science:

  • Pediatric Psychiatry
  • Child Neurology
  • Critical Care Medicine

Background:

  • Pediatric delirium diagnosis is challenging in critically ill children.
  • Standardized diagnostic criteria are essential for reliable assessment.

Purpose of the Study:

  • To evaluate the interrater reliability of pediatric delirium diagnosis by child psychiatrists.
  • To assess the reliability of psychiatric interviews and exams in diverse pediatric populations.

Main Methods:

  • Seventeen critically ill patients (0-21 years) were assessed for delirium using DSM-IV criteria.
  • Two blinded child psychiatrists independently diagnosed delirium.
  • Interrater reliability was measured using Cohen's kappa coefficient.

Main Results:

  • High interrater reliability was observed for the psychiatric assessment (Cohen's κ = 0.94).
  • Excellent reliability was consistent across different age groups, developmental statuses, and intubation conditions (κ range 0.81-1.00).

Conclusions:

  • Psychiatric interviews and exams are highly reliable for diagnosing delirium in pediatric patients.
  • A developmental approach is recommended for diagnosing delirium in challenging pediatric populations.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
408
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
395
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
410